Oxidation of the aromatic amino acids tryptophan and tyrosine disrupts their anabolic effects on bone marrow mesenchymal stem cells. El
Glycogen synthase kinase-3 (GSK3) first identified as a metabolic enzyme involved in carbohydrate metabolism was later identified to be activated during various diseases such as cancer, bipolar disease and diabetes. The role of GSK3 that exists in two different isoforms namely GSK3α and GSK3β is not yet characterized in any disease states. Our study was focused on characterizing the isoform specific role of GSK3α and GSK3β in the regulation of prostate cancer progression and metastasis through specific gene knockdown and through preclinical studies in rodent models. This manuscript published in the journal 'Oncotarget' discusses the specific role of GSK3α during the early stages of prostate cancer growth via regulation of apoptosis and proliferation, and the importance of GSK3β during the advanced stages of prostate cancer. We identified that GSK3β is involved in the differentiation of early stage prostate cancer cells into more aggressive ones through a process known as epithelial-to-mesenchymal transition, thus promoting its entry into circulation and subsequent metastasis to distant tissues such as lung and bone. Our study generates reasonable optimism on the beneficial effects of targeting one or both of the GSK3 isoforms for the management of advanced prostate cancer. Study was funded by the UGA College of Pharmacy funds and departmental TRI Grant. 
